Computational models of the glucoregulatory system constitute a powerful tool for preclinical evaluation and mechanistic insight into therapeutics. However, in the case of diabetes, there is a dearth ...

Ard J, Fitch A, Fruh S, Herman L. Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists. Adv Ther. 2021;38 (6):2821-2839. doi:10.1007/s12325 ...

Specifically, we looked at the underlying mechanisms by which certain members of the MAPK protein family, the p38 MAPKs, regulate the glucagon action that can lead to the high blood sugar levels ...

Journal Nature DOI 10.1038/s41586-023-06420-x Article Title Tail engagement of arrestin at the glucagon receptor Article Publication Date 9-Aug-2023 ...

Related: Expert Reveals a Drug-Free Way to Mimic The Effects of Ozempic Glucagon-like peptide-1 (GLP-1 ... GLP-1's release is ...

MTVA READ THE FULL MTVA RESEARCH REPORT Business Update DA-1726 48 mg Cohort Study Extended to Eight Weeks On August 6, 2025, ...

Pemvidutide is currently being evaluated in the phase 2 RECLAIM study, which is enrolling approximately 100 patients with AUD and obesity or overweight.